Literature DB >> 9611667

Ventricular enlargement in poor-outcome schizophrenia.

K L Davis1, M S Buchsbaum, L Shihabuddin, J Spiegel-Cohen, M Metzger, E Frecska, R S Keefe, P Powchik.   

Abstract

BACKGROUND: A subset of patients with schizophrenia, defined on the basis of longitudinal deficits in self-care, may show a classic ("Kraepelinian") degenerative course. An independent validator of the phenomenologically defined Kraepelinian subtype might be provided by a structural indicator of possible brain degeneration: ventricular size as measured by computed tomography (CT).
METHODS: To examine whether Kraepelinian patients would show a differential increase in ventricular size over time, two CT scans were conducted at intervals separated by > 4 years, an average of 5 years. Fifty-three male patients with DSM-III-R diagnoses of chronic schizophrenia were subdivided into Kraepelinian (n = 22; mean age = 42 +/- 6 years) and non-Kraepelinian (n = 31; mean age = 38 +/- 12.2 years) subgroups. Kraepelinian patients were defined on the basis of longitudinal criteria: > 5 years of complete dependence on others for life necessities and care, lack of employment, and sustained symptomatology. Thirteen normal elderly volunteers (mean age = 60 +/- 17.8) were also scanned at 4-year intervals. CT measurements were made by raters without knowledge of subgroup membership. A semiautomated computer program was used to trace the anterior horn, lateral ventricles, and temporal horns for each slice level on which they were clearly seen.
RESULTS: The ventricles showed a bilateral increase in size over the 4-year interval in the Kraepelinian subgroup, more marked in the left hemisphere than the right. By contrast, neither the non-Kraepelinian subgroup nor the normal volunteers showed significant CT changes from scan 1 to scan 2.
CONCLUSIONS: Thus, the longitudinal dysfunctions in self-care that characterize the Kraepelinian patients were associated with an independent indicator of brain abnormality.

Entities:  

Mesh:

Year:  1998        PMID: 9611667     DOI: 10.1016/s0006-3223(97)00553-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

Review 1.  New insights on the neuroanatomy of schizophrenia.

Authors:  G D Pearlson
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 3.  The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.

Authors:  Lynn E DeLisi
Journal:  Schizophr Bull       Date:  2008-02-08       Impact factor: 9.306

Review 4.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

5.  The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay.

Authors:  Philip D Harvey; Abraham Reichenberg; Christopher R Bowie; Thomas L Patterson; Robert K Heaton
Journal:  Biol Psychiatry       Date:  2010-03-03       Impact factor: 13.382

6.  The Course and Correlates of Everyday Functioning in Schizophrenia.

Authors:  Abraham Reichenberg; Concetta Feo; Davide Prestia; Christopher R Bowie; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-03-01

7.  Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Authors:  Mohamed Ahmed; Dara M Cannon; Cathy Scanlon; Laurena Holleran; Heike Schmidt; John McFarland; Camilla Langan; Peter McCarthy; Gareth J Barker; Brian Hallahan; Colm McDonald
Journal:  Neuropsychopharmacology       Date:  2015-04-01       Impact factor: 7.853

Review 8.  What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

Authors:  Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

9.  Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.

Authors:  Dean F Salisbury; Noriomi Kuroki; Kiyoto Kasai; Martha E Shenton; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2007-05

10.  [Not Available].

Authors:  Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Open Neuroimag J       Date:  2009-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.